Topic: Health and Medicine
David Ewing Duncan and Dr. Moira Gunn speak with Joshua Boger, the President and CEO of Vertex Pharmaceuticals. They discuss rational drug design: how Vertex re-engineered their HIV/AIDS drug into one for Hepatitis C.
Dr. Moira Gunn speaks with science journalist David Ewing Duncan, who talks about new European Union legislation to test all the toxic chemicals which surround us in modern life - from furniture to clothing, from automobiles to the workplace.
Larry Ellingson, former chair of the American Diabetes Association, speaks with Dr. Moira Gunn about the role of pharmacy in diabetes and other chronic diseases.
Dr. Moira Gunn speaks with Dr. Ren Ee Chee about the focus of biotech in Singpore - from Dengue Fever to difficult strains of tuberculosis to bird flu.
Nurturing a fledgling nonprofit takes dedication, focus, and maybe even a few miracles. In this audio lecture, Van Jones offers a compelling look at life in the nonprofit sector, sharing his own story and some key tips for making a real difference. Collaboration, communication, tenacity, integrity, and irrational exuberance are just a few of the qualities needed to grow a good idea into a sustainable force for social progress.
Dr. Louann Brizendine, neuropsychiatrist at UCSF Medical School, speaks with Dr. Moira Gunn about her new book "The Female Brain."
Dr. Jenny Harry, deputy CEO and Executive VP for Diagnostics at Proteome Systems, talks to Dr. Moira Gunn about a far more effective test for prostate cancer.
In 1982, ophthalmologist Oliver Foot founded Orbis Flying Eye Hospital, a unique mobile teaching facility housed in a DC-10 jet aircraft. In this audio interview With Globeshakers host Tim Zak, he discusses how his organization brings dedicated eye care professionals to the developing world to restore eyesight through surgery and other treatments.
Dr. Una Ryan, President & CEO of Avant, speaks with Dr. Moira Gunn about their goals for making new vaccines.
Dr. Moira Gunn looks at a new way to take common drugs - a spray on the skin - by talking to Igor Gonda, the CEO of the Australian-based Acrux.
